160 related articles for article (PubMed ID: 16492915)
1. Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication therapy.
Tsai CJ; Herrera-Goepfert R; Tibshirani RJ; Yang S; Mohar A; Guarner J; Parsonnet J
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):272-80. PubMed ID: 16492915
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.
Jorge O; Cuello Carrión FD; Jorge A; Ciocca DR
Rev Esp Enferm Dig; 2003 Feb; 95(2):97-104, 89-96. PubMed ID: 12760717
[TBL] [Abstract][Full Text] [Related]
3. [Effect of Helicobacter pylori infection and eradication on proliferative kinetics of the gastric mucosa].
Unger Z; Prónai L; Szaleczky E; Zágoni T; Molnár B; Tulassay Z
Orv Hetil; 2000 Dec; 141(50):2695-700. PubMed ID: 11189675
[TBL] [Abstract][Full Text] [Related]
4. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis.
Nardone G; Staibano S; Rocco A; Mezza E; D'armiento FP; Insabato L; Coppola A; Salvatore G; Lucariello A; Figura N; De Rosa G; Budillon G
Gut; 1999 Jun; 44(6):789-99. PubMed ID: 10323879
[TBL] [Abstract][Full Text] [Related]
5. Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori.
Sawaya M; Yoshimura T; Shimoyama T; Munakata A; Fukuda S
J Clin Gastroenterol; 2008 Apr; 42(4):351-5. PubMed ID: 18277906
[TBL] [Abstract][Full Text] [Related]
6. Changes in aberrant DNA methylation after Helicobacter pylori eradication: a long-term follow-up study.
Shin CM; Kim N; Lee HS; Park JH; Ahn S; Kang GH; Kim JM; Kim JS; Lee DH; Jung HC
Int J Cancer; 2013 Nov; 133(9):2034-42. PubMed ID: 23595635
[TBL] [Abstract][Full Text] [Related]
7. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
8. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis?
Meining A; Morgner A; Miehlke S; Bayerdörffer E; Stolte M
Best Pract Res Clin Gastroenterol; 2001 Dec; 15(6):983-98. PubMed ID: 11866488
[TBL] [Abstract][Full Text] [Related]
9. Expression of Lewis antigens and their precursors in gastric mucosa: relationship with Helicobacter pylori infection and gastric carcinogenesis.
Lee HS; Choe G; Kim WH; Kim HH; Song J; Park KU
J Pathol; 2006 May; 209(1):88-94. PubMed ID: 16456898
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis.
Valenzuela MA; Canales J; Corvalán AH; Quest AF
World J Gastroenterol; 2015 Dec; 21(45):12742-56. PubMed ID: 26668499
[TBL] [Abstract][Full Text] [Related]
11. K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer.
Watari J; Tanaka A; Tanabe H; Sato R; Moriichi K; Zaky A; Okamoto K; Maemoto A; Fujiya M; Ashida T; Das KM; Kohgo Y
J Clin Pathol; 2007 Aug; 60(8):921-6. PubMed ID: 16997920
[TBL] [Abstract][Full Text] [Related]
12. The impact of Helicobacter pylori on EGF, EGF receptor, and the c-erb-B2 expression.
Jurkowska G; Piotrowska-Staworko G; Guzińska-Ustymowicz K; Kemona A; Świdnicka-Siergiejko A; Łaszewicz W; Dąbrowski A
Adv Med Sci; 2014 Sep; 59(2):221-6. PubMed ID: 25051417
[TBL] [Abstract][Full Text] [Related]
13. Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis.
Compare D; Rocco A; Liguori E; D'Armiento FP; Persico G; Masone S; Coppola-Bottazzi E; Suriani R; Romano M; Nardone G
J Clin Pathol; 2011 Aug; 64(8):677-82. PubMed ID: 21617174
[TBL] [Abstract][Full Text] [Related]
14. Expression of mutant type-p53 products in H pylori-associated chronic gastritis.
Kodama M; Murakami K; Okimoto T; Sato R; Watanabe K; Fujioka T
World J Gastroenterol; 2007 Mar; 13(10):1541-6. PubMed ID: 17461446
[TBL] [Abstract][Full Text] [Related]
15. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori eradication and associated changes in the gastric mucosa.
Murakami K; Kodama M; Sato R; Okimoto T; Watanabe K; Fujioka T
Expert Rev Anti Infect Ther; 2005 Oct; 3(5):757-64. PubMed ID: 16207167
[TBL] [Abstract][Full Text] [Related]
17. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of IL-1β and TNF-α polymorphisms on the H. pylori-related gastric pre-malignant condition.
Tahara T; Shibata T; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Nakagawa Y; Nagasaka M; Iwata M; Nakamura M; Hirata I; Arisawa T
Hepatogastroenterology; 2012; 59(120):2416-20. PubMed ID: 23169178
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of connexin 32 and connexin 43 in patients with gastric precancerous lesion after eradication of Helicobacter pylori].
Jia Y; Xu CX; Yang WB
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):628-33. PubMed ID: 18667778
[TBL] [Abstract][Full Text] [Related]
20. Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression.
Ierardi E; Francavilla A; Balzano T; Traversa A; Principi M; Monno RA; Amoruso A; Ingrosso M; Pisani A; Panella C
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):214-9. PubMed ID: 9646212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
